Evidence map›Paper›PMID 33442054›Full record

ArticleNature protocols2021

Author Correction: Dynamic single-cell phenotyping of immune cells using the microfluidic platform DropMap.

Yacine Bounab, Klaus Eyer, Sophie Dixneuf, Magda Rybczynska, Cécile Chauvel, Maxime Mistretta, Trang Tran, Nathan Aymerich, Guilhem Chenon, Jean-François Llitjos and 14 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Yacine Bounab *BIOASTER Technology Research Institute, Lyon, France.
Klaus Eyer *Laboratoire de Colloïdes et Matériaux Divisés (LCMD), École Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris Sciences et Lettres (PSL), CNRS UMR8231, Paris, France.
Sophie DixneufBiological Microsystems and Advanced Optics Engineering Unit, BIOASTER Technology Research Institute, Paris, France.
Magda RybczynskaLaboratoire de Colloïdes et Matériaux Divisés (LCMD), École Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris Sciences et Lettres (PSL), CNRS UMR8231, Paris, France.
Cécile ChauvelBiological Microsystems and Advanced Optics Engineering Unit, BIOASTER Technology Research Institute, Paris, France.
Maxime MistrettaBIOASTER Technology Research Institute, Lyon, France.
Trang TranBiological Microsystems and Advanced Optics Engineering Unit, BIOASTER Technology Research Institute, Paris, France.
Nathan AymerichLaboratoire de Colloïdes et Matériaux Divisés (LCMD), École Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris Sciences et Lettres (PSL), CNRS UMR8231, Paris, France.
Guilhem ChenonLaboratoire de Colloïdes et Matériaux Divisés (LCMD), École Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris Sciences et Lettres (PSL), CNRS UMR8231, Paris, France.
Jean-François LlitjosMedical Intensive Care Unit, Cochin Hospital, Paris, France.
Fabienne VenetEA7426-Pathophysiology of Injury-Induced Immunosuppression, Université Claude Bernard Lyon-1 - HCL - bioMérieux, Lyon, France.
Guillaume MonneretEA7426-Pathophysiology of Injury-Induced Immunosuppression, Université Claude Bernard Lyon-1 - HCL - bioMérieux, Lyon, France.
Iain A GillespieValue, Evidence & Outcomes, GlaxoSmithKline, Stevenage, Hertfordshire, UK.
Pierre CortezR&D, Sanofi Aventis, Chilly-Mazarin, France.
Virginie MoucadelEA7426-Pathophysiology of Injury-Induced Immunosuppression, Université Claude Bernard Lyon-1 - HCL - bioMérieux, Lyon, France.
Alexandre PachotMedical Diagnostic Discovery Department (MD3), bioMérieux S.A., Lyon, France.
Alain TroeschBiological Microsystems and Advanced Optics Engineering Unit, BIOASTER Technology Research Institute, Paris, France.
Philippe LeissnerBiological Microsystems and Advanced Optics Engineering Unit, BIOASTER Technology Research Institute, Paris, France.
Julien TextorisEA7426-Pathophysiology of Injury-Induced Immunosuppression, Université Claude Bernard Lyon-1 - HCL - bioMérieux, Lyon, France.ORCID http://orcid.org/0000-0002-3821-9337
Jérôme BibetteLaboratoire de Colloïdes et Matériaux Divisés (LCMD), École Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris Sciences et Lettres (PSL), CNRS UMR8231, Paris, France.
Cyril GuyardBiological Microsystems and Advanced Optics Engineering Unit, BIOASTER Technology Research Institute, Paris, France.
Jean BaudryLaboratoire de Colloïdes et Matériaux Divisés (LCMD), École Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris Sciences et Lettres (PSL), CNRS UMR8231, Paris, France. jean.baudry@espci.fr.ORCID http://orcid.org/0000-0002-5526-499X
Andrew D GriffithsLaboratoire de Biochimie (LBC), École Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris Sciences et Lettres (PSL), CNRS UMR8231, Paris, France. andrew.griffiths@espci.fr.ORCID http://orcid.org/0000-0002-0808-3539
Christophe VédrineBIOASTER Technology Research Institute, Lyon, France. christophe.vedrine@bioaster.org.ORCID http://orcid.org/0000-0002-3760-3767

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33442054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.